1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Assays & kits
1.2.3 Instruments & Analyzers
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Physicians’ Offices
1.3.3 Hospitals & ICUs
1.3.4 Research Institutes
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Molecular Diagnostic Solution Market Perspective (2017-2028)
2.2 Point-of-care Molecular Diagnostic Solution Growth Trends by Region
2.2.1 Point-of-care Molecular Diagnostic Solution Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Point-of-care Molecular Diagnostic Solution Historic Market Size by Region (2017-2022)
2.2.3 Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028)
2.3 Point-of-care Molecular Diagnostic Solution Market Dynamics
2.3.1 Point-of-care Molecular Diagnostic Solution Industry Trends
2.3.2 Point-of-care Molecular Diagnostic Solution Market Drivers
2.3.3 Point-of-care Molecular Diagnostic Solution Market Challenges
2.3.4 Point-of-care Molecular Diagnostic Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue
3.1.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue (2017-2022)
3.1.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Players (2017-2022)
3.2 Global Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Molecular Diagnostic Solution Revenue
3.4 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio
3.4.1 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Molecular Diagnostic Solution Revenue in 2021
3.5 Point-of-care Molecular Diagnostic Solution Key Players Head office and Area Served
3.6 Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
3.7 Date of Enter into Point-of-care Molecular Diagnostic Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Molecular Diagnostic Solution Breakdown Data by Type
4.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Type (2017-2022)
4.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028)
5 Point-of-care Molecular Diagnostic Solution Breakdown Data by Application
5.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Application (2017-2022)
5.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
6.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type
6.2.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
6.2.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
6.2.3 North America Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
6.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Application
6.3.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
6.3.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
6.3.3 North America Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
6.4 North America Point-of-care Molecular Diagnostic Solution Market Size by Country
6.4.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
6.4.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
7.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type
7.2.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
7.2.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
7.2.3 Europe Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application
7.3.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
7.3.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
7.3.3 Europe Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
7.4 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country
7.4.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
7.4.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
8.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type
8.2.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
8.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application
8.3.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
8.4 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region
8.4.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
9.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type
9.2.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
9.2.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
9.2.3 Latin America Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
9.3 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application
9.3.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
9.3.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
9.3.3 Latin America Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
9.4 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country
9.4.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
9.4.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
10.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type
10.2.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Type (2017-2028)
10.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application
10.3.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Application (2017-2028)
10.4 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country
10.4.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Introduction
11.1.4 Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Details
11.2.2 F. Hoffmann-La Roche AG Business Overview
11.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Introduction
11.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.2.5 F. Hoffmann-La Roche AG Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Introduction
11.3.4 Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Developments
11.4 BioMerieux
11.4.1 BioMerieux Company Details
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Introduction
11.4.4 BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.4.5 BioMerieux Recent Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Details
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.5.5 Bio-Rad Laboratories, Inc. Recent Developments
11.6 Cepheid, Inc.
11.6.1 Cepheid, Inc. Company Details
11.6.2 Cepheid, Inc. Business Overview
11.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.6.4 Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.6.5 Cepheid, Inc. Recent Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Introduction
11.7.4 Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.7.5 Danaher Corporation Recent Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Introduction
11.8.4 Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.8.5 Johnson and Johnson Recent Developments
11.9 Bayer Healthcare
11.9.1 Bayer Healthcare Company Details
11.9.2 Bayer Healthcare Business Overview
11.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Introduction
11.9.4 Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.9.5 Bayer Healthcare Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Assays & kits
Table 3. Key Players of Instruments & Analyzers
Table 4. Key Players of Software & Services
Table 5. Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2017-2022)
Table 9. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2023-2028)
Table 11. Point-of-care Molecular Diagnostic Solution Market Trends
Table 12. Point-of-care Molecular Diagnostic Solution Market Drivers
Table 13. Point-of-care Molecular Diagnostic Solution Market Challenges
Table 14. Point-of-care Molecular Diagnostic Solution Market Restraints
Table 15. Global Point-of-care Molecular Diagnostic Solution Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Players (2017-2022)
Table 17. Global Top Point-of-care Molecular Diagnostic Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2021)
Table 18. Ranking of Global Top Point-of-care Molecular Diagnostic Solution Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
Table 22. Date of Enter into Point-of-care Molecular Diagnostic Solution Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2017-2022)
Table 26. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2023-2028)
Table 28. Global Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Application (2017-2022)
Table 30. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Application (2023-2028)
Table 32. North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product
Table 65. Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 66. Abbott Laboratories Recent Developments
Table 67. F. Hoffmann-La Roche AG Company Details
Table 68. F. Hoffmann-La Roche AG Business Overview
Table 69. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product
Table 70. F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 71. F. Hoffmann-La Roche AG Recent Developments
Table 72. Becton, Dickinson and Company Company Details
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product
Table 75. Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickinson and Company Recent Developments
Table 77. BioMerieux Company Details
Table 78. BioMerieux Business Overview
Table 79. BioMerieux Point-of-care Molecular Diagnostic Solution Product
Table 80. BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 81. BioMerieux Recent Developments
Table 82. Bio-Rad Laboratories, Inc. Company Details
Table 83. Bio-Rad Laboratories, Inc. Business Overview
Table 84. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 85. Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 86. Bio-Rad Laboratories, Inc. Recent Developments
Table 87. Cepheid, Inc. Company Details
Table 88. Cepheid, Inc. Business Overview
Table 89. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 90. Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 91. Cepheid, Inc. Recent Developments
Table 92. Danaher Corporation Company Details
Table 93. Danaher Corporation Business Overview
Table 94. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product
Table 95. Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 96. Danaher Corporation Recent Developments
Table 97. Johnson and Johnson Company Details
Table 98. Johnson and Johnson Business Overview
Table 99. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product
Table 100. Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 101. Johnson and Johnson Recent Developments
Table 102. Bayer Healthcare Company Details
Table 103. Bayer Healthcare Business Overview
Table 104. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product
Table 105. Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 106. Bayer Healthcare Recent Developments
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Molecular Diagnostic Solution Market Share by Type: 2021 VS 2028
Figure 2. Assays & kits Features
Figure 3. Instruments & Analyzers Features
Figure 4. Software & Services Features
Figure 5. Global Point-of-care Molecular Diagnostic Solution Market Share by Application: 2021 VS 2028
Figure 6. Physicians’ Offices Case Studies
Figure 7. Hospitals & ICUs Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Point-of-care Molecular Diagnostic Solution Report Years Considered
Figure 11. Global Point-of-care Molecular Diagnostic Solution Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Point-of-care Molecular Diagnostic Solution Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Point-of-care Molecular Diagnostic Solution Market Share by Region: 2021 VS 2028
Figure 14. Global Point-of-care Molecular Diagnostic Solution Market Share by Players in 2021
Figure 15. Global Top Point-of-care Molecular Diagnostic Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2021
Figure 17. North America Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 19. North America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 20. North America Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 21. United States Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 25. Europe Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 26. Europe Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 27. Germany Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Share by Region (2017-2028)
Figure 37. China Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 47. Mexico Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Share by Country (2017-2028)
Figure 53. Turkey Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Abbott Laboratories Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 57. F. Hoffmann-La Roche AG Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 58. Becton, Dickinson and Company Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 59. BioMerieux Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 60. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 61. Cepheid, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 62. Danaher Corporation Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 63. Johnson and Johnson Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 64. Bayer Healthcare Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
